image
Cumberland Pharmaceuticals Inc. CPIX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 4.42
-1.34 %
$ 61.7 M
Market Cap
-9.59
P/E
BALANCE SHEET
75.6 M ASSETS
-7.57%
Growth Rates
1Year -7.57%
3Years -3.63%
5Years -6.28%
7Years -2.95%
10Years -2.30%
53 M LIABILITIES
0.99%
Growth Rates
1Year 0.99%
3Years 8.21%
5Years -0.16%
7Years 8.84%
10Years 13.73%
22.9 M EQUITY
-22.80%
Growth Rates
1Year -22.80%
3Years -18.88%
5Years -14.87%
7Years -13.70%
10Years -11.86%
BALANCE SHEET DECOMPOSITION
Balance Sheet Cumberland Pharmaceuticals Inc.
image
Current Assets 36.5 M
Cash & Short-Term Investments 18 M
Receivables 11.7 M
Other Current Assets 6.79 M
Non-Current Assets 39.1 M
Long-Term Investments 0
PP&E 6.45 M
Other Non-Current Assets 32.7 M
23.77 %15.48 %8.98 %8.54 %43.23 %Total Assets$75.6m
Current Liabilities 31.6 M
Accounts Payable 13.9 M
Short-Term Debt 5.46 M
Other Current Liabilities 12.3 M
Non-Current Liabilities 21.4 M
Long-Term Debt 15.1 M
Other Non-Current Liabilities 6.3 M
26.23 %10.29 %23.10 %28.50 %11.88 %Total Liabilities$53.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005
ASSETS
Cash & Cash Equivalents 18.0 18.3 19.8 27.0 24.8 28.2 27.9 45.4 34.5 38.2 39.9 40.9 54.3 70.6 65.9 78.7 11.8 10.8 6.3 5.5
Short Term Investments 0 0 0 0 0 0 8.3 4.7 15.6 14.6 14.8 14.0 16.7 0 0 0 0 0 0 0
Receivables 11.7 9.8 13.2 6.9 12.4 7.9 7.8 8.4 7.3 6.1 5.5 4.5 6.0 7.1 5.1 6.2 3.1 2.4 5.1 2.4
Inventory 4.0 4.6 9.4 8.4 10.6 8.9 27.8 6.7 5.4 4.3 5.6 5.7 6.2 5.8 7.7 4.8 1.8 0.9 0.7 0.5
Other Current Assets 2.8 3.0 3.1 6.7 2.2 5.2 3.0 3.5 2.7 4.0 5.0 3.5 4.0 3.9 2.3 3.5 1.0 0.7 0.6 93.7 K
Total Current Assets 36.5 35.7 45.9 45.7 50.0 50.2 74.9 68.7 65.5 67.1 70.8 68.7 87.2 87.3 81.0 93.2 17.7 14.8 12.6 8.6
PP&E 6.5 7.0 5.5 1.5 2.6 3.7 0.8 0.5 0.5 0.5 0.7 0.9 1.2 1.1 1.2 0.9 0.4 0.5 0.4 0.4
Intangible Assets 18.0 22.6 30.6 24.0 28.1 30.9 33.7 21.4 22.2 21.2 21.6 15.5 9.5 7.0 7.4 8.0 8.5 9.2 9.8 37 K
Goodwill 0.9 0.9 0.9 0.9 0.9 0.9 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 (0.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 13.8 15.5 10.0 12.5 14.9 18.9 2.5 2.5 2.1 1.9 1.8 1.3 0.6 67.8 K 0.1 0.4 3.4 2.7 25.9 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 75.6 81.8 92.9 84.5 96.5 104.5 112.7 93.2 93.4 91.9 95.4 87.6 98.6 95.5 92.1 103.7 31.1 28.9 26.5 10.2
LIABILITIES
Accounts Payable 13.9 14.0 10.8 9.6 13.4 10.0 11.1 9.0 8.0 2.9 3.2 2.0 2.8 1.5 2.1 5.6 3.3 1.9 3.4 1.0
Short Term Debt 5.5 0.3 0.2 1.0 3.2 0.9 0 0 0 0 0 0 0 0 2.7 9.2 1.2 3.2 1.8 0.3
Other Current Liabilities 12.3 13.6 17.6 8.7 9.1 13.2 16.7 8.7 6.8 9.5 10.5 5.5 5.3 5.1 4.4 3.8 3.1 3.0 3.5 1.7
Total Current Liabilities 31.6 28.0 28.6 19.3 25.7 24.2 27.8 17.7 14.8 12.4 13.7 7.5 8.1 6.6 9.2 18.6 7.6 8.1 8.7 3.0
Long Term Debt 15.1 18.1 20.8 15.1 16.1 20.6 20.0 9.8 4.1 1.7 0 0 5.0 4.9 5.1 10.9 5.6 0.9 3.6 0
Deferred Tax Income 0 0 (2.5) (3.4) 0.7 1.3 2.0 2.1 3.2 0 0 0 0 0.6 0 0 0 0 0 0
Other Liabilities 6.3 6.5 7.6 7.5 7.9 8.7 9.3 1.8 1.4 1.0 0.9 0.8 0 0.6 0 1.9 0.4 3.1 3.1 0
Total Liabilities 53.0 52.5 57.0 41.9 49.6 53.5 57.1 29.3 20.3 15.1 14.7 8.3 13.0 12.7 14.3 31.5 13.6 12.2 15.4 3.9
EQUITY
Common Stock 46.8 47.1 47.5 48.5 49.1 49.9 51.1 52.4 54.6 57.3 61.9 63.1 67.2 0 70.8 1 930.0 0 0 0 0
Retained Earnings (24.0) (17.5) (11.2) (5.6) (2.1) 1.2 4.7 11.7 18.6 19.5 18.8 16.4 18.5 12.7 7.0 4.5 1.5 (3.3) (7.4) (11.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Equity 22.5 29.3 36.0 42.6 46.9 51.1 55.6 63.9 73.1 76.8 80.8 79.3 85.6 82.8 77.7 72.2 17.6 16.7 11.1 6.2
Total Liabilities and Equity 75.6 81.8 92.9 84.5 96.5 104.5 112.7 93.2 93.4 91.9 95.4 87.6 98.6 95.5 92.1 103.7 31.1 28.9 26.5 10.2
SHARES OUTSTANDING
Common Shares Outstanding 14.1 14.3 14.6 14.9 15.2 15.4 15.6 15.9 15.7 16.7 17.6 18.3 19.6 20.3 20.3 14.2 10.1 10.0 9.8 9.5